Noah Goodman
Chief Business Officer at Kymera Therapeutics · 6 reported transactions in 1 company · latest trade Jul 1, 2026
Their trades
Sold | Jul 1, 2026 | Jul 1, 2026 close $114.20 → Oct 29, 2026 close $122.60. S&P 500 +3.6% over the same days. | ||
Sold | Jun 25, 2026 | Jun 25, 2026 close $116.46 → Oct 29, 2026 close $122.60. S&P 500 +5.2% over the same days. | ||
Sold | Jun 25, 2026 | Jun 25, 2026 close $116.46 → Oct 29, 2026 close $122.60. S&P 500 +5.2% over the same days. | ||
Sold | Jun 22, 2026 | Jun 22, 2026 close $99.45 → Oct 29, 2026 close $122.60. S&P 500 +3.8% over the same days. |
$387.3K
Jul 1, 2026 close $114.20 → Oct 29, 2026 close $122.60. S&P 500 +3.6% over the same days.
$297.5K
Jun 25, 2026 close $116.46 → Oct 29, 2026 close $122.60. S&P 500 +5.2% over the same days.
$272.5K
Jun 25, 2026 close $116.46 → Oct 29, 2026 close $122.60. S&P 500 +5.2% over the same days.
$247.5K
Jun 22, 2026 close $99.45 → Oct 29, 2026 close $122.60. S&P 500 +3.8% over the same days.